Leukine 250MCG VIL INJ (5PKG)

Active Awarded Last action

Contract number
75A50323F80027
Awardee
Awarding agency
Obligated
$133,514,342

Award facts

Opportunity
  • 75A50323Q00021 Solicitation number
Contract value 100% obligated
$133,514,342.37 Current and potential, with all options
Completion date 88% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Lexington, MA 02421, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00007 · Exercise optional ordering period 2 for leukine 250MCG vial injectables $34,199,252
Exercise an Option P00006 · Leukine 250MCG QTY 14,635 at the unit price of $1,079.60 $15,799,946
Other Administrative Action P00005 $0
Exercise an Option P00004 $19,999,590
Exercise an Option P00003 $19,114,318
Change Order P00002 $0
Exercise an Option P00001 $22,201,974
Original award $22,199,262

About this award

The Office of the Assistant Secretary for Preparedness and Response issued a delivery order to Partner Therapeutics, Inc. on September 26, 2023, exercising the optional ordering period 2 for Leukine 250mcg vial injectables, with a ceiling value of $133.5 million and firm fixed pricing.

This delivery order is issued under the GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB). Place of performance is Lexington, MA. The order extends through March 29, 2027, and covers supply of Leukine 250mcg vial injectables as a medical countermeasure.

Quick answers

Who was awarded contract 75A50323F80027?

75A50323F80027 was awarded to Partner Therapeutics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 26, 2023.

How much is contract 75A50323F80027 worth?

The government has obligated $133,514,342 on 75A50323F80027.

Is contract 75A50323F80027 an order under another contract?

Yes. 75A50323F80027 is a delivery order under 36F79723D0171, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75A50323F80027 competed?

The extent of competition for 75A50323F80027 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award